These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 9652997)

  • 1. Two cases of severe clinical and histologic hepatotoxicity associated with troglitazone.
    Gitlin N; Julie NL; Spurr CL; Lim KN; Juarbe HM
    Ann Intern Med; 1998 Jul; 129(1):36-8. PubMed ID: 9652997
    [No Abstract]   [Full Text] [Related]  

  • 2. Hepatic injury due to troglitazone.
    Malik AH; Prasad P; Saboorian MH; Thiele DL; Malet PF
    Dig Dis Sci; 2000 Jan; 45(1):210-4. PubMed ID: 10695637
    [No Abstract]   [Full Text] [Related]  

  • 3. Fatal hepatotoxicity associated with troglitazone.
    Vella A; de Groen PC; Dinneen SF
    Ann Intern Med; 1998 Dec; 129(12):1080. PubMed ID: 9867776
    [No Abstract]   [Full Text] [Related]  

  • 4. Severe but reversible hepatitis induced by troglitazone.
    Schiano T; Dolehide K; Hart J; Baker AL
    Dig Dis Sci; 2000 May; 45(5):1039-42. PubMed ID: 10795774
    [No Abstract]   [Full Text] [Related]  

  • 5. Troglitazone-induced fulminant hepatitis: report of a case with autopsy findings.
    Li H; Heller DS; Leevy CB; Zierer KG; Klein KM
    J Diabetes Complications; 2000; 14(3):175-7. PubMed ID: 10989325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Substituting for troglitazone (Rezulin).
    Med Lett Drugs Ther; 2000 Apr; 42(1076):36. PubMed ID: 10803176
    [No Abstract]   [Full Text] [Related]  

  • 7. Hepatotoxicity with thiazolidinediones: is it a class effect?
    Scheen AJ
    Drug Saf; 2001; 24(12):873-88. PubMed ID: 11735645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Late-onset troglitazone-induced hepatic dysfunction.
    Bell DS; Ovalle F
    Diabetes Care; 2000 Jan; 23(1):128-9. PubMed ID: 10857986
    [No Abstract]   [Full Text] [Related]  

  • 9. Failure to develop hepatic injury from rosiglitazone in a patient with a history of troglitazone-induced hepatitis.
    Lenhard MJ; Funk WB
    Diabetes Care; 2001 Jan; 24(1):168-9. PubMed ID: 11194222
    [No Abstract]   [Full Text] [Related]  

  • 10. Troglitazone-associated hepatic failure.
    Booth AM; Caldwell SH; Iezzoni JC
    Am J Gastroenterol; 2000 Feb; 95(2):557-8. PubMed ID: 10685776
    [No Abstract]   [Full Text] [Related]  

  • 11. FDA reviews troglitazone.
    Donnelly R
    Diabetes Obes Metab; 1999 Mar; 1(2):65-6. PubMed ID: 11220513
    [No Abstract]   [Full Text] [Related]  

  • 12. Troglitazone-associated hepatic failure.
    Misbin RI
    Ann Intern Med; 1999 Feb; 130(4 Pt 1):330. PubMed ID: 10068399
    [No Abstract]   [Full Text] [Related]  

  • 13. Severe hepatotoxicity associated with troglitazone.
    Herrine SK; Choudhary C
    Ann Intern Med; 1999 Jan; 130(2):163-4. PubMed ID: 10068372
    [No Abstract]   [Full Text] [Related]  

  • 14. Severe cholestatic hepatitis from troglitazone in a patient with nonalcoholic steatohepatitis and diabetes mellitus.
    Menon KVN ; Angulo P; Lindor KD
    Am J Gastroenterol; 2001 May; 96(5):1631-4. PubMed ID: 11374713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid-onset subfulminant liver failure associated with troglitazone.
    Jagannath S; Rai R
    Ann Intern Med; 2000 Apr; 132(8):677. PubMed ID: 10766693
    [No Abstract]   [Full Text] [Related]  

  • 16. Hepatotoxicity of the thiazolidinediones.
    Tolman KG; Chandramouli J
    Clin Liver Dis; 2003 May; 7(2):369-79, vi. PubMed ID: 12879989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Troglitazone for non-insulin-dependent diabetes mellitus.
    Med Lett Drugs Ther; 1997 May; 39(1001):49-51. PubMed ID: 9164446
    [No Abstract]   [Full Text] [Related]  

  • 18. Troglitazone-induced fulminant hepatic failure. Acute Liver Failure Study Group.
    Murphy EJ; Davern TJ; Shakil AO; Shick L; Masharani U; Chow H; Freise C; Lee WM; Bass NM
    Dig Dis Sci; 2000 Mar; 45(3):549-53. PubMed ID: 10749332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel antidiabetic drug, troglitazone--reason for hope and concern.
    Imura H
    N Engl J Med; 1998 Mar; 338(13):908-9. PubMed ID: 9516229
    [No Abstract]   [Full Text] [Related]  

  • 20. Troglitazone: the discovery and development of a novel therapy for the treatment of Type 2 diabetes mellitus.
    Parker JC
    Adv Drug Deliv Rev; 2002 Nov; 54(9):1173-97. PubMed ID: 12393300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.